Jardiance®
10 mg| Tablets
General information
From April 1, 2023, the use of Jardiance® (empagliflozin) in patients with chronic heart failure regardless of ejection fraction (HFrEF, HFmrEF and HFpEF) is regularly reimbursed through the health insurance. Due to the extension of the reimbursement of Jardiance®(empagliflozin), the reimbursement scheme by TBR Nederland is lifted. The Pharmacy or patient can declare dispensations between the period March 3, 2022 to April 1, 2023 up to September 1, 2023 at the latest.
For a complete reimbursment overview of Jardiance® 10 mg, click here.
| Dose | Jardiance® 10 mg |
| Type | Pill |
| Active ingredient | EMPAGLIFLOZIN |
Reimbursement
Conditions
Jardiance®(empagliflozin) 10 mg was fully reimbursed from March 3, 2022 to April 1, 2023 through TBR Nederland. Issues that have taken place during this period can be submitted until September 1, 2023 at the latest.
Who can submit a claim
1. Patients or their carer can claim the costs for Jardiance® 10 mg online or by post.
2. Pharmacists can only claim this medicine online, on behalf of the patient.
From when till when can you submit a claim
Submit a claim online
Patients can claim online and will receive their reimbursement within 5 working days.
Submit a claim by post
Patients can claim by post and will receive their reimbursement within 15 working days.
Please mail the Claim Form and attachments to:
TBR Nederland
Postbus 8011
1180 LA Amstelveen
Need some help?
If you need any assistance please read our Frequently Asked Questions.
Still does not work? Please contact our Servicedesk via e-mail or call the Jardiance® 10 mg service-number 088-0026715.
PC-NL-104713
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine
